Evaluation of the induction of vasoactive mediators from equine digital vein endothelial cells by endotoxin

Am J Vet Res. 2008 Mar;69(3):349-55. doi: 10.2460/ajvr.69.3.349.

Abstract

Objective: To determine the effect of endotoxin (lipopolysaccharide [LPS]) on vasoactive mediator production by cultured equine digital vein endothelial cells (EDVECs).

Sample population: EDVECs obtained from forelimb digital veins of 7 healthy adult horses.

Procedures: EDVECs were incubated with or without LPS (1 microg/mL) for 0, 2, 4, 6, 22, and 24 hours. The EDVECs were incubated for 18 hours with LPS (10 pg/mL to 1 microg/mL) with or without ibuprofen, cycloheximide, or L-nitroarginine methyl ester. Medium concentrations of prostacyclin, cyclic guanosine monophosphate, endothelin-1, and thromboxane A(2) were determined. Changes in inducible nitric oxide synthase and cyclooxygenase-2 expression were determined.

Results: LPS stimulated mean 4.2- and 14.1-fold increases in EDVEC prostacyclin and cyclic guanosine monophosphate production, respectively, after 22 hours. These effects were LPS concentration-dependent (LPS concentrations that induced a response halfway between the maximum response and baseline of 1.50 and 1.22 ng/mL, respectively). The LPS-induced cyclic guanosine monophosphate production was significantly inhibited (to basal concentrations) by L-nitroarginine methyl ester, and prostacyclin production was inhibited by cycloheximide and ibuprofen. Production of thromboxane A(2) by EDVECs was not detected. Endothelin-1 accumulated in the medium, but LPS did not enhance its production. Inducible nitric oxide synthase expression in EDVECs was not detected with the available antibodies, whereas LPS stimulated cyclooxygenase-2 expression in a time- and concentration-dependent manner.

Conclusions and clinical relevance: LPS stimulated vasoactive mediator production by equine endothelial cells, which may play a role in LPS-induced digital hypoperfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclic GMP / metabolism
  • Cycloheximide / pharmacology
  • Cyclooxygenase 2 / metabolism
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism*
  • Endothelin-1 / metabolism
  • Enzyme Inhibitors / pharmacology
  • Epoprostenol / metabolism
  • Forelimb
  • Horse Diseases / chemically induced*
  • Horse Diseases / enzymology
  • Horse Diseases / metabolism*
  • Horses
  • Ibuprofen / pharmacology
  • Immunohistochemistry
  • Lipopolysaccharides / pharmacology*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase Type II / metabolism
  • Thromboxane A2 / metabolism

Substances

  • Endothelin-1
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Thromboxane A2
  • Cycloheximide
  • Epoprostenol
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Cyclic GMP
  • NG-Nitroarginine Methyl Ester
  • Ibuprofen